These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Ovarian Carcinoma Histotype Based on Limited Sampling: A Prospective Study Comparing Cytology, Frozen Section, and Core Biopsies to Full Pathologic Examination. Hoang LN; Zachara S; Soma A; Köbel M; Lee CH; McAlpine JN; Huntsman D; Thomson T; van Niekerk D; Singh N; Gilks CB Int J Gynecol Pathol; 2015 Nov; 34(6):517-27. PubMed ID: 26107565 [TBL] [Abstract][Full Text] [Related]
4. Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions. Köbel M; Luo L; Grevers X; Lee S; Brooks-Wilson A; Gilks CB; Le ND; Cook LS Int J Gynecol Pathol; 2019 Jul; 38(4):353-362. PubMed ID: 29901523 [TBL] [Abstract][Full Text] [Related]
5. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy. Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843 [TBL] [Abstract][Full Text] [Related]
7. Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer. Takeda T; Tsuji K; Banno K; Yanokura M; Kobayashi Y; Tominaga E; Aoki D J Gynecol Oncol; 2018 May; 29(3):e29. PubMed ID: 29400022 [TBL] [Abstract][Full Text] [Related]
8. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer]. Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072 [TBL] [Abstract][Full Text] [Related]
9. Synchronous endometrial and ovarian cancer in Lynch syndrome with a Takeda T; Banno K; Yanokura M; Anko M; Kobayashi A; Sera A; Takahashi T; Adachi M; Kobayashi Y; Hayashi S; Nomura H; Hirasawa A; Tominaga E; Aoki D Mol Clin Oncol; 2018 Nov; 9(5):479-484. PubMed ID: 30402230 [TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics. Pelizzo MR; Pennelli G; Zane M; Galuppini F; Colletti PM; Merante Boschin I; Rubello D Biomed Pharmacother; 2015 Aug; 74():9-16. PubMed ID: 26349957 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival. Engqvist H; Parris TZ; Rönnerman EW; Söderberg EMV; Biermann J; Mateoiu C; Sundfeldt K; Kovács A; Karlsson P; Helou K Oncotarget; 2018 Oct; 9(80):35162-35180. PubMed ID: 30416686 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of Lynch syndrome associated ovarian cancer. Woolderink JM; De Bock GH; de Hullu JA; Hollema H; Zweemer RP; Slangen BFM; Gaarenstroom KN; van Beurden M; van Doorn HC; Sijmons RH; Vasen HFA; Mourits MJE Gynecol Oncol; 2018 Aug; 150(2):324-330. PubMed ID: 29880284 [TBL] [Abstract][Full Text] [Related]
13. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers. Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. Kast K; Dobberschütz C; Sadowski CE; Pistorius S; Wimberger P Arch Gynecol Obstet; 2016 Nov; 294(6):1299-1303. PubMed ID: 27535758 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China. Wang Y; Xue F; Broaddus RR; Tao X; Xie SS; Zhu Y Int J Gynecol Cancer; 2009 May; 19(4):651-6. PubMed ID: 19509565 [TBL] [Abstract][Full Text] [Related]
16. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma. Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271 [TBL] [Abstract][Full Text] [Related]
18. Lynch Syndrome: A Primer for Urologists and Panel Recommendations. Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197 [TBL] [Abstract][Full Text] [Related]